IL6 and cancer: Interleukin 6 (IL-6) is one of the most studied cytokines that activate STAT3 via JAK1, JAK2, or TYK2 (16), leading to the expression of genes that support cancer cell survival, proliferation, metastasis, and angiogenesis (16, 17, 18).